Based on reported studies, exogenous expression of p53 in human cancer cells during replication of oncolytic viruses such as Vesicular Stomatitis Virus (VSV), Newcastle disease virus (NDV), and adenovirus enhance the cell death leading to anti-tumor effects of these viruses [25–28]. Here, TP53 is linked to cancer.